You haven't searched anything yet.
Company Overview
Rhythm is a global, commercial-stage biopharmaceutical company committed to transforming the care of people living with rare melanocortin-4 receptor (MC4R) pathway diseases. Working at Rhythm means that you are part of a team that’s passionate about transforming the lives of people living with hyperphagia (pathological, insatiable hunger) and severe obesity caused by rare MC4R pathway diseases. We recognize the courage it takes for patients and their caregivers to begin their journey of advocacy to find the answers they need. Their courage inspires us to challenge convention, ask bold questions and seek answers for them. Every day, we strive for excellence through our willingness to adapt, learn, and our tenacity to overcome barriers, together.
Opportunity Overview
Rhythm Pharmaceuticals is focused on making a positive impact on patients living with rare genetic diseases of obesity (RGDO). As a Territory Manager (TM), you will play an integral role in supporting the transformation of the care of people living with Bardet-Biedl syndrome (BBS) by providing disease education to a targeted physician community.
You will work closely with cross-functional partners to support education around clinical diagnosis to support IMCIVREE’s current launch in Bardet-Biedl syndrome (BBS) and other marketed indications in POMC/PCSK1 or LEPR deficiencies (PPL). This position will report to the Sr. US Field Sales Director, East.
The current territory includes North and South Carolina.
Responsibilities and Duties
Qualifications and Skills
This role is field based. Candidates applying must be willing and able to travel frequently.
More About Rhythm
Rhythm is a global, commercial-stage biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity. This is a key biological pathway that regulates weight and hunger. A central element of Rhythm’s mission is to improve the understanding of these diseases and develop management strategies for patients who have no treatment options available to them. Rhythm was founded in 2008 and is based in Boston, MA. The company’s clinical development program is currently focused on several rare MC4R pathway diseases. For healthcare professionals, visit www.RareObesity.com for more information. For those who may be affected or would like to learn more, visit www.LEADforRareObesity.com for more information.
Full Time
Pharmaceutical
$92k-132k (estimate)
04/10/2024
07/07/2024
rhythmtx.com
BOSTON, MA
50 - 100
2008
DAVID MEEKER PRES-CEO
$5M - $10M
Pharmaceutical
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity. The company is leveraging the Rhythm Engine -- comprised of its TEMPO Registry, GO-ID genotyping study and Uncovering Rare Obesity program -- to improve the understanding, diagnosis and potentially the treatment of these disorders. For healthcare professionals, visit www.UNcommonObesity.com for more information. For patients and caregivers, visit www.LEADforRareObesity.com for more information.